USE OF NADPH IN PREPARING MEDICINES FOR TREATMENT OF CARDIOVASCULAR AND CEREBROVASCULAR DISEASES

Title:

USE OF NADPH IN PREPARING MEDICINES FOR TREATMENT OF CARDIOVASCULAR AND CEREBROVASCULAR DISEASES

Document Type and Number:

WIPO Patent Application WO/2016/131321

Kind Code:

A1

Abstract:

The use of reduced nicotinamide adenine dinucleotide phosphate (NADPH) in preparing medicines for the treatment or prevention of cardiovascular and cerebrovascular diseases, and medicines for the treatment or prevention of cardiovascular and cerebrovascular diseases using NADPH as the active ingredient, said cardiovascular and cerebrovascular diseases including thrombosis diseases, hypertension, coronary artery disease, blood vessel hardening, and atherosclerosis.

Inventors:

QIN ZHENGHONG (CN)
LI MEI (CN)

Application Number:

PCT/CN2015/095392

Publication Date:

August 25, 2016

Filing Date:

November 24, 2015

Export Citation:

Click for automatic bibliography generation Help

Assignee:

SUZHOU REN BEN PHARMACEUTICAL COMPANY (CN)

International Classes:

A61K31/7048; A61K9/00; A61P7/02; A61P9/00; A61P9/10; A61P9/12

Foreign References:

CN104840478A	2015-08-19
CN103340890A	2013-10-09
US5668114A	1997-09-16
US5945452A	1999-08-31

Other References:

MA, HAIFENG ET AL.: "The Effect of Coenzyme NADH on Biochemical of Myocardial Ischemia Reperfusion Injury in Rats", ACTA ACADEMIAE MEDICINAE WEIFANG, no. 1, 31 January 2009 (2009-01-31), pages 29 - 32, ISSN: 1004-3101
LIU, JIANBIN ET AL.: "Protective Effects of NADH on Cardiac Fibroblasts Apoptosis Induced by Hydrazine", MEDICAL JOURNAL OF CHINESE PEOPLE'S LIBERATION ARMY, vol. 33, no. 3, 31 March 2008 (2008-03-31), pages 305 - 306

Attorney, Agent or Firm:

SUNSHINE INTELLECTUAL PROPERTY INTERNATIONAL CO., LTD (CN)
北京三聚阳光知识产权代理有限公司 (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: USE OF NADPH IN PREPARING MEDICINES FOR TREATMENT OF HEART DISEASES

Next Patent: NAVIGATION METHOD, APPARATUS, AND DEVICE